Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1 FNS-I sequence optimization
1. Experimental Material
pETDuet-1 vector: purchased from Youbao organisms; plasmid extraction kit, gel recovery kit: purchased from OMEGA; restriction enzymes were purchased from NEB.
The standard compounds apigenin (CAS number: 520-36-5) and naringenin (CAS number: 480-41-1) are purchased from Shanghai leaf Biotech limited, and have purity of more than 98%. Other reagents are domestic analytical pure or chromatographic pure reagents and are purchased from national pharmaceutical group chemical reagent limited.
Clone competent cell DH5 α, expression competent cell Rosetta (DE 3): purchased from holo-gold.
Liquid phase detection conditions: phase A: 0.1% formic acid water, phase B: acetonitrile; separation conditions are as follows: 0-20min 20% B phase-55%, 20-22min 55-B phase-100%, 22-27min 100%, 27-35min100% B phase-20% B phase, 35-40min, 20-20% B phase; detection wavelength: 340nm, column temperature: at 30 ℃. And (3) chromatographic column: thermo syncronis C18 reverse phase column (250 mm. Times.4.6 mm,5 μm).
2, FNS-I sequence modification:
based on codon preference of escherichia coli, GC content, codon balance and the like are comprehensively considered, an original FNS-I sequence (SEQ ID NO.1 is optimized to obtain 3 optimized sequences FNS-IM1, FNS-IM2 and FNS-IM3, nucleotide sequences of the sequences are respectively shown in SEQ ID NO.2-4, and the three sequences are synthesized by a whole gene sequence of Suzhou Jinzhi biological science and technology limited company.
Example 2 construction of engineering bacteria
1. Respectively adding NcoI and BamHI at two ends of the three optimized FNS-I gene sequences and the original FNS-I gene sequence, synthesizing the optimized FNS-I gene by using a gene synthesis technology, and constructing cloning vectors pUC57FNS-IM1, pUC57FNS-IM2, pUC57FNS-IM3 and pUC57FNS-I;
2. constructing a recombinant expression vector, double digesting pETDuet-1 plasmid and obtained pUC57FNS-IM1, pUC57FNS-IM2, pUC57FNS-IM3 and pUC57FNS-I plasmids respectively by NcoI and BamHI, obtaining pETDuet-1 and FNS-IM1, FNS-IM2, FNS-IM3 and pUC57FNS-I fragments by glue recovery, then connecting pETDuet-1 with FNS-IM1, FNS-IM2, FNS-IM3 and pUC57FNS-I respectively by using T4DNA ligase, transforming DH5 alpha competent cells by the connecting products, coating ampicillin resistant plates, culturing overnight at constant temperature of 37 ℃, screening positive recombinants, obtaining pETDue-FNS-IM1 plasmids, pETDue-pES-IM 2 plasmids, TDue-pES-3 plasmids and FNS-IM3 plasmids by extracting the plasmids;
3. respectively transforming the pETDue-FNS-IM1 plasmid, pETDue-FNS-IM2 plasmid, pETDue-FNS-IM3 plasmid and pETDue-FNS-I plasmid obtained in the above steps into escherichia coli Rosetta (DE 3), coating an ampicillin resistance plate, inverting overnight at the constant temperature of 37 ℃ for culturing, screening to obtain positive recombinants, namely obtaining FNS-IM1, FNS-IM2, FNS-IM3 and FNS-I engineering bacteria respectively, and preserving glycerin tubes.
Example 3 production of apigenin by fermentation of engineering bacteria
FNS-IM1, FNS-IM2, FNS-IM3, FNS-I engineering bacteria strains are respectively subjected to amplification culture according to the following methods:
(1) Under the aseptic condition, taking a ring strain from a glycerol tube by using an inoculating ring, transplanting the ring strain into a primary seed culture medium, culturing at 37 ℃ and 240rpm until the OD600 is between 3.0 and 4.0 to obtain primary seed bacterial liquid;
(2) Transferring the primary seed bacterial liquid into a secondary seed culture medium according to the inoculation amount of 6-10%, and culturing at 37 ℃ and 240rpm for 3-5 h to obtain secondary seed bacterial liquid;
(3) Inoculating the cultured secondary seed bacterial liquid into a fermentation tank according to the inoculation amount of 6-10%, wherein the initial fermentation parameters are as follows: the temperature is 37 ℃, the rotating speed is 200rpm, the pH value is 7.0, the ventilation volume is 50L/h, and the tank pressure is 0.05MPa; along with the prolonging of the fermentation time, the bacteria concentration is gradually increased, and the dissolved oxygen is controlled to be 20-40% by adjusting the rotating speed and the ventilation quantity; when the dissolved oxygen and the pH value are simultaneously and rapidly increased, feeding materials in a flowing manner is started; when OD600 reaches 20-25 ℃, the temperature is reduced to 30 ℃, then 0.2mM inducer is added, the fermentation is continued for 8-12 h, then the mixture is put into a tank, and thalli are collected by low-temperature centrifugation and refrigerated.
2. Identifying the production capacity of the strain on apigenin:
(1) After FNS-IM1, FNS-IM2, FNS-IM3 and FNS-I engineering bacteria are washed by a potassium phosphate buffer solution with PH =6, cells are respectively placed in the following transformation systems for apigenin transformation (three groups are repeated): the transformation system comprises:
5% of wet bacteria of the engineering bacteria, 0.1M potassium phosphate buffer, 2.0M naringenin (apigenin synthesis substrate, figure 1), 5mM ascorbate and 10 μ MFeSO 4 The pH was adjusted to 6 with 2mol/L NaOH solution and the conversion was carried out at a temperature of 35 ℃ and 150rpm for 10 hours.
The substrate conversion rate is calculated by the substrate content existing in the conversion system, the naringenin content is calculated by preparing different concentration gradients (0, 0.05,0.1,0.5,1,2.5,5,7.5, 10, 15 and 20 g/L) of naringenin standard substances, measuring an A240 value and drawing a standard curve.
(2) And (3) conversion result:
TABLE 1
|
Apigenin product concentration (mg/L)
|
Conversion (%)
|
FNS-IM1
|
108.55±2.67
|
87
|
FNS-IM2
|
121.34±1.89
|
98
|
FNS-IM3
|
101.46±2.21
|
82
|
FNS-I (control group)
|
88.67±1.87
|
72 |
As can be seen from the results in Table 1, the optimized flavone synthases FNS-IM1, FNS-IM2 and FNS-IM3 have conversion rates superior to those of the original sequence FNS-I, wherein the FNS-IM2 has the optimal conversion capacity, and the conversion rate can reach 98%.
EXAMPLE 4 preparation of Terylene macrobio fiber containing apigenin component
Large biological fiber: bioactive molecules are added into fibers (cotton, hemp, wool, silk, viscose, polyester, nitrile and brocade) for modification, so as to produce the active fiber with biological functions. The polyester macrobio fiber containing the apigenin component prepared by the invention is an active fiber with antibacterial and antiviral functions and the like, which is prepared by adding the apigenin component in the production process of the polyester fiber.
1. Preparation of SiO by sol-gel method 2 Nano-microspheres:
weighing 0.5g of CTAB, dissolving in 1000mL of deionized water, stirring at 40 ℃, dropwise adding a NaOH solution after the solution is clarified, and adjusting the pH to 11.8; the temperature was then raised to 80 ℃; after 30min, 2.5mL TEOS is added, and the mixture is continuously stirred for 2h at the temperature of 80 ℃; standing the obtained white suspension, cooling to room temperature, centrifuging, washing with deionized water and absolute ethyl alcohol repeatedly for 3 times at a rotating speed of 9000r/min, drying the obtained white gel in a vacuum drying oven for 12 hours, placing the dried sample in a muffle furnace, and calcining at 550 ℃ for 6 hours; cooling to obtain white solid powder which is mesoporous SiO 2 And (3) nanoparticles. Grinding and crushing for later use to prepare the mesoporous SiO 2 The granularity of the nano particles is 100 +/-10 nm, and the aperture is 2.5 +/-0.5 nm; 2. concentrating and purifying the apigenin produced in the example 3 according to a conventional method in the field to obtain a pure apigenin product (the purity is more than or equal to 95%), ultrasonically dissolving the pure apigenin product by using a 95% ethanol solution to obtain a 30% apigenin suspension, and weighing 10g of mesoporous SiO prepared in the step 1 2 Sequentially adding nano powder and 0.02g of dispersant XD-5040 into 500mL of deionized water, and shearing and dispersing by using a magnetic stirrer at 250r/min; obtaining SiO containing apigenin component 2 Nano composite dispersion liquid, volatilizing the solvent of the dispersion liquid to obtain mesoporous SiO containing apigenin component 2 Grinding and crushing a molecular nest (the particle size is 9000 meshes) for later use;
firstly, the mesoporous SiO containing apigenin component prepared in step 2 2 Vacuum drying the molecular nest and the polyester chip at 180 ℃ for 24h; then, according to the following steps of 1:10, adding 0.1 percent of dispersant XD-5040, 0.5 percent of antioxidant 1098 and 0.2 percent of coupling agent KH-550 into a double-screw extruder for mixing and granulation, controlling the melting temperature at 260-280 ℃ and the screw rotating speed at 260r/min; obtaining a master batch containing apigenin; 3. mixing the mother particles containing apigenin with common polymerEster slices were as per 1:20, 0.2 percent of dispersant PT-200E, 0.2 percent of antioxidant KB-6 and 0.15 percent of coupling agent Z-6020 are added into a double-screw extruder for mixing and spinning, the spinning speed is 1700m/min, the stretching temperature is 80 ℃, the side-blown cooling air temperature is 30 ℃, the side-blown air speed is 0.5m/s, the total stretching ratio is 5 times, and the winding speed is 1050m/min, thus preparing the polyester macrobio-fiber containing apigenin.
The polyester macrobio fiber containing the apigenin component is made into fiber fabric through a spinning production line, and the bacteriostasis rate of the fiber fabric containing the apigenin component and the bacteriostasis rate of the fiber fabric after 100 times of standard washing (GB/T8629-2017) are tested according to GB/T20944.2-2007. The results are shown in table 2 below.
TABLE 2
Through detection, the fabric obtained by spinning the polyester macrobio-fiber containing the apigenin component has obvious inhibition effects on staphylococcus aureus, escherichia coli and candida albicans on the surface of human skin, and still has excellent antibacterial property after being washed for many times.
Unless otherwise stated, the proportions described in the present examples are mass proportions, and the percentages described are mass percentages.
Although the present invention has been described in detail with reference to the foregoing embodiments, it will be apparent to those skilled in the art that modifications may be made to the embodiments described above, or equivalents may be substituted for elements thereof. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Sequence listing
<110> Baicao Bingbio technology (Qingdao) Co., ltd
<120> apigenin prepared by genetically engineered bacteria and application thereof in polyester fiber manufacturing
<130> 5
<141> 2022-06-08
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1074
<212> DNA
<213> Artificial Sequence
<400> 1
atggctccaa caactattac tgcattggcc aaggaaaaaa cacttaactc tgattttgtc 60
cgggatgagg atgagcgtcc caaagttgcc tacaatcaat tcagcactga aattcccatt 120
atttctttag ctggtatcga tgatgattcc aatggcagga gacctgaggt gtgtcgtaaa 180
atagtggagg ccttcgaaga ctgggggatt ttccaggtag ttgatcacgg tattgacagc 240
ggtttgatcg cggaaatgtc tcgtctgtct cgtgaattct ttgctttgcc tgccgaggag 300
aaacttcggt atgatactac tggtggaaag agaggcggct tcactatctc cactcatctt 360
cagggtgacg atgtgaagga ttggcgtgag tttgttgttt atttttcgta cccagtcgat 420
gctcgggact actcgagatg gcctgataag ccagagggat ggaggtctgt tacggaggtt 480
tatagtgaga agttgatggc gctaggtgcc aagttactgg aagtgctatc agaggccatg 540
gggcttgaaa aagaggctct tacagaggct tgtgtgaaca tggaacagaa agtgttgatt 600
aattactatc ctacatgtcc ccaaccggac ttgacacttg gagtcagaag gcacacggat 660
ccgggtacga ttaccatttt gcttcaggac atggttgggg ggttacaggc taccagggat 720
ggcggcaaaa cttggattac tgttcagcct gtcgagggag cttttgtcgt caatttgggt 780
gatcatggtc attatttgag caatggaagg ttcaagaatg ccgatcacca agcagtagtg 840
aattcaactt ctagcagatt gtctatcgca actttccaga acccggctca gaatgctata 900
gtgtatccat taaagatcag ggagggcgag aagccaattc ttgaggaggc catgacatac 960
gccgagatgt ataagaaaaa catgactaaa catattgagg tggctaccca gaagaaattg 1020
gccaaggaga aaagattgca gaacgagaag gccaagctgg agacgaaatt ttag 1074
<210> 2
<211> 1074
<212> DNA
<213> Artificial Sequence
<400> 2
atggctccag cagctattac tgcattggcc aaagaaaaaa cacttaactc tgattttgtc 60
cgggatgaag atgaacgtcc cagaattgcc tacagtcagt tcagcactga aattcccatt 120
atttctttag ctggtatcga tgatgattcc aatggcagga gacctgaagt gtgtcgtaaa 180
atagtggaag ccttcgaaaa ctgggggatt ttccaggtag ttgatcacgg tattgacagc 240
ggtttgatcg cggaaatgtc tcgtctgtct cgtgaattct ttgctttgcc tgccgaagaa 300
aaacttcggt atgatactac tggtggaaaa agaagcggct tcactatctc cactcatctt 360
cagggtgacg atgtgaaaga ttggcgtgaa tttgttgttt atttttcgta cccagtcgat 420
gctcgggact actcgaaatg gcctgataaa ccagaaggat ggaagtctgt tacggaagtt 480
tatagtgaaa agttgatggc gctaggtgcc aaattactgg aaatgctatc agaagccatg 540
gggcttgaaa aaaaggctct tacagaagct tgtgtgaaca tggaacagaa agtgttgatt 600
aattactatc ctacatgtcc ccagccggac ttgacacttg gaatcagaaa gcacacggat 660
ccgggtacga ttaccatttt gcttcaggac atggttgggg ggttacaggc taccagggat 720
ggcggcagaa cttggattac tgttcagcct gtcgaaggaa cttttgtcgt cagtttgggt 780
gatcatggtc attatttgaa cagtggaaag ttcagaaatg ccgatcacca agcagtagtg 840
aattcagctt ctagcagatt gtctatcgca actttccaga acccggctca gaatgctata 900
gtgtatccat taaaaatcag ggaaggcgaa aaaccagttc ttgaagaagc catgacatac 960
gccgaaatgt ataaaaaaaa catgactaaa catattgaag tggctaccca gaaaaaattg 1020
gccagaaaga aaaaattgca gaacgaaaaa gccagactgg agacgaaatt ttag 1074
<210> 3
<211> 1074
<212> DNA
<213> Artificial Sequence
<400> 3
atggctccag cagctattat tgcattggcc aaagaaaaaa catttaactc tgattttgtc 60
cgggatgaag atgaacgtcc cagaattgcc tatagtcagt tcagcattga aattcccatt 120
atttctttag ctggtatcga tgatgattcc aatggcagga gacctgaagt gtgtcgtaaa 180
atagtggaag ccttcgaaaa ctgggggatt ttccaggtag ttgatcatgg tattgacagc 240
ggtttgatcg cggaaatgtc tcgtctgtct cgtgaattct ttgctttgcc tgccgaagaa 300
aaacttcggt atgatattat tggtggaaaa agaagcggct tcattatctc cattcatctt 360
cagggtgacg atgtgaaaga ttggcgtgaa tttgttgttt atttttcgta cccagtcgat 420
gctcgggact actcgaaatg gcctgataaa ccagaaggat ggaagtctgt tatggaagtt 480
tatagtgaaa agttgatggc gctaggtgcc aaattattgg aaatgctatc agaagccatg 540
gggcttgaaa aaaaggctct tatagaagct tgtgtgaaca tggaacagaa agtgttgatt 600
aattattatc ctatatgtcc ccagccggac ttgacatttg gaatcagaaa gcatacggat 660
ccgggtatga ttatcatttt gcttcaggac atggttgggg ggttataggc tatcagggat 720
ggcggcagaa cttggattat tgttcagcct gtcgaaggaa cttttgtcgt cagtttgggt 780
gatcatggtc attatttgaa cagtggaaag ttcagaaatg ccgatcatca agcagtagtg 840
aattcagctt ctagcagatt gtctatcgca actttccaga acccggctca gaatgctata 900
gtgtatccat taaaaatcag ggaaggcgaa aaaccagttc ttgaagaagc catgacatat 960
gccgaaatgt ataaaaaaaa catgactaaa catattgaag tggctatcca gaaaaaattg 1020
gccagaaaga aaaaattgca gaacgaaaaa gccagactgg agacgaaatt ttag 1074
<210> 4
<211> 1074
<212> DNA
<213> Artificial Sequence
<400> 4
atggctccaa caactattac tgcattggcc aaggtaaaaa catttaactc tgattttgtc 60
cgggttgagg atgagcgtcc caaagttgcc tacaatcaat tcagcattga aattcccatt 120
atttctttaa ctggtatcga tgatgattcc aatggcaggt gacctgaggt gtgtcgtaaa 180
ataatggtgg ccttcgaaga ctgggggttt ttccaggtaa ttgatcatgg tattgacagc 240
ggtttgatcg cggtaatgtc tcgtctgtct cgtgaattct ttgctttgcc tgccgaggtg 300
aaacttcggt atgatactac tggtggtaag agaggcggct tcattatctc cattcatctt 360
cagggtgacg atgtgaaggt ttggcgtgag tttgttgttt atttttcgta cccagtcgat 420
gctcgggtct actcgagatg gcctgataag ccagagggtt ggtggtctgt tacggtggtt 480
tataatgaga agttgatggc gctaagtgcc aagttactgg aagtgctatc agaggccatg 540
gggcttgaaa aagaggctct tacagaggct tgtgtgaaca tggtacagaa agtgttgatt 600
aattactatc ctacatgtcc ccaaccggtc ttgacatttg gagtcagaag gcatacggtt 660
ccgggtacga ttaccatttt gcttcaggtc atggttgggg ggttacaggc taccagggtt 720
ggcggcaaaa cttggtttac tgttcagcct gtcgagggtg cttttgtcgt caatttgggt 780
gatcatggtc attatttgag caatggtagg ttcaagaatg ccgatcatca agcagtaatg 840
aattcaactt ctaacagatt gtctatcgca actttccaga acccggctca gaatgctata 900
gtgtatccat taaagatcag ggtgggcgag aagccaattc ttgaggtggc catgacatac 960
gccgagatgt ataagaaaaa catgactaaa catattgagg tggctaccca gaagaaattg 1020
gccaaggtga aaagattgca gaacgagaag gccaagctgg agacgaaatt ttaa 1074